Top compounds associated with response to CTAGE9


Feature Type Standardized
Nominal ANOVA
mRNA PD 153035 CTRPv2 pan-cancer AAC 0.15 0.002
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.003
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.003
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.15 0.004
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.13 0.004
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.004
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.13 0.004
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.005
mRNA MST-312 CTRPv2 pan-cancer AAC -0.12 0.005
Download CSV